Search

Susan Nmn Ungar

Examiner (ID: 13594)

Most Active Art Unit
1642
Art Unit(s)
2899, 1642, 1806
Total Applications
662
Issued Applications
234
Pending Applications
203
Abandoned Applications
225

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6755326 [patent_doc_number] => 20030003103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Sequences for targeting metastatic cells' [patent_app_type] => new [patent_app_number] => 10/151055 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14456 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20030003103.pdf [firstpage_image] =>[orig_patent_app_number] => 10151055 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/151055
Sequences for targeting metastatic cells May 20, 2002 Abandoned
09/958398 Telomerase-specific cancer vaccine May 16, 2002 Abandoned
Array ( [id] => 6668913 [patent_doc_number] => 20030113897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Mutant p21Cip1/WAF1 and cell growth control and cell growth control' [patent_app_type] => new [patent_app_number] => 10/142174 [patent_app_country] => US [patent_app_date] => 2002-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 48759 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113897.pdf [firstpage_image] =>[orig_patent_app_number] => 10142174 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/142174
Mutant p21Cip1/WAF1 and cell growth control and cell growth control May 8, 2002 Abandoned
Array ( [id] => 6653112 [patent_doc_number] => 20030008840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Methods for treating cancer' [patent_app_type] => new [patent_app_number] => 10/140802 [patent_app_country] => US [patent_app_date] => 2002-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11293 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008840.pdf [firstpage_image] =>[orig_patent_app_number] => 10140802 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/140802
Methods for treating cancer May 6, 2002 Abandoned
Array ( [id] => 6766125 [patent_doc_number] => 20030100525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Survivin, a protein that inhibits cellular apoptosis, and its modulation' [patent_app_type] => new [patent_app_number] => 10/138618 [patent_app_country] => US [patent_app_date] => 2002-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 25449 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100525.pdf [firstpage_image] =>[orig_patent_app_number] => 10138618 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/138618
Survivin, a protein that inhibits cellular apoptosis, and its modulation May 5, 2002 Issued
Array ( [id] => 6660146 [patent_doc_number] => 20030134790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer' [patent_app_type] => new [patent_app_number] => 10/139814 [patent_app_country] => US [patent_app_date] => 2002-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15064 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134790.pdf [firstpage_image] =>[orig_patent_app_number] => 10139814 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/139814
Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer May 1, 2002 Abandoned
Array ( [id] => 6725028 [patent_doc_number] => 20030207340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Sequences encoding human neoplastic marker' [patent_app_type] => new [patent_app_number] => 10/138195 [patent_app_country] => US [patent_app_date] => 2002-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15265 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207340.pdf [firstpage_image] =>[orig_patent_app_number] => 10138195 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/138195
Sequences encoding human neoplastic marker Apr 30, 2002 Abandoned
Array ( [id] => 6796927 [patent_doc_number] => 20030175801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals' [patent_app_type] => new [patent_app_number] => 10/124862 [patent_app_country] => US [patent_app_date] => 2002-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 29411 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175801.pdf [firstpage_image] =>[orig_patent_app_number] => 10124862 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/124862
Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals Apr 17, 2002 Abandoned
Array ( [id] => 6782938 [patent_doc_number] => 20030064385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Genes expressed in breast cancer as prognostic and therapeutic targets' [patent_app_type] => new [patent_app_number] => 10/120583 [patent_app_country] => US [patent_app_date] => 2002-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29150 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064385.pdf [firstpage_image] =>[orig_patent_app_number] => 10120583 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/120583
Genes expressed in breast cancer as prognostic and therapeutic targets Apr 10, 2002 Abandoned
Array ( [id] => 6473650 [patent_doc_number] => 20020151517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Nucleosome-based anti-tumor compositions' [patent_app_type] => new [patent_app_number] => 10/118802 [patent_app_country] => US [patent_app_date] => 2002-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6303 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151517.pdf [firstpage_image] =>[orig_patent_app_number] => 10118802 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/118802
Nucleosome-based anti-tumor compositions Apr 8, 2002 Abandoned
Array ( [id] => 6679763 [patent_doc_number] => 20030229904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer' [patent_app_type] => new [patent_app_number] => 10/120885 [patent_app_country] => US [patent_app_date] => 2002-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 94773 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229904.pdf [firstpage_image] =>[orig_patent_app_number] => 10120885 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/120885
Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer Apr 8, 2002 Abandoned
Array ( [id] => 6787199 [patent_doc_number] => 20030138438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Compositions and methods for the therapy and diagnosis of lung cancer' [patent_app_type] => new [patent_app_number] => 10/117982 [patent_app_country] => US [patent_app_date] => 2002-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70965 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138438.pdf [firstpage_image] =>[orig_patent_app_number] => 10117982 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/117982
Compositions and methods for the therapy and diagnosis of lung cancer Apr 4, 2002 Abandoned
Array ( [id] => 7447669 [patent_doc_number] => 20040003418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer' [patent_app_type] => new [patent_app_number] => 10/107532 [patent_app_country] => US [patent_app_date] => 2002-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 64 [patent_no_of_words] => 120650 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20040003418.pdf [firstpage_image] =>[orig_patent_app_number] => 10107532 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/107532
Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer Mar 24, 2002 Abandoned
Array ( [id] => 7126907 [patent_doc_number] => 20050058651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Compositions and methods to prevent metastasis from primary malignancies' [patent_app_type] => utility [patent_app_number] => 10/468388 [patent_app_country] => US [patent_app_date] => 2002-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13711 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20050058651.pdf [firstpage_image] =>[orig_patent_app_number] => 10468388 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/468388
Compositions and methods to prevent metastasis from primary malignancies Mar 20, 2002 Abandoned
10/018396 Extracellular camp-dependent protein kinase in diagnosis, prognosis and treatment of cancer Mar 19, 2002 Abandoned
Array ( [id] => 6730051 [patent_doc_number] => 20030186241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Human choline/ethanolamine kinase (HCEK)-related gene variant associated with lung cancers' [patent_app_type] => new [patent_app_number] => 10/102556 [patent_app_country] => US [patent_app_date] => 2002-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5609 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186241.pdf [firstpage_image] =>[orig_patent_app_number] => 10102556 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/102556
Human choline/ethanolamine kinase (HCEK)-related gene variant associated with lung cancers Mar 19, 2002 Abandoned
Array ( [id] => 6710496 [patent_doc_number] => 20030170245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Activation of matriptase and diagnostic and therapeutic methods based thereon' [patent_app_type] => new [patent_app_number] => 10/087987 [patent_app_country] => US [patent_app_date] => 2002-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 15632 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170245.pdf [firstpage_image] =>[orig_patent_app_number] => 10087987 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/087987
Activation of matriptase and diagnostic and therapeutic methods based thereon Mar 4, 2002 Abandoned
Array ( [id] => 6047650 [patent_doc_number] => 20020168662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Sperm protein 17 for the diagnosis and treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/082959 [patent_app_country] => US [patent_app_date] => 2002-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6913 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20020168662.pdf [firstpage_image] =>[orig_patent_app_number] => 10082959 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/082959
Sperm protein 17 for the diagnosis and treatment of cancer Feb 25, 2002 Issued
Array ( [id] => 6375152 [patent_doc_number] => 20020119189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Nucleosome-based anti-tumor compositions' [patent_app_type] => new [patent_app_number] => 10/081223 [patent_app_country] => US [patent_app_date] => 2002-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6351 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119189.pdf [firstpage_image] =>[orig_patent_app_number] => 10081223 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/081223
Nucleosome-based anti-tumor compositions Feb 21, 2002 Abandoned
Array ( [id] => 6655553 [patent_doc_number] => 20030077603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Methods and compositions for diagnosis of hepatoma' [patent_app_type] => new [patent_app_number] => 10/079596 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 35178 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077603.pdf [firstpage_image] =>[orig_patent_app_number] => 10079596 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/079596
Methods and compositions for diagnosis of hepatoma Feb 18, 2002 Abandoned
Menu